Compile Data Set for Download or QSAR
Report error Found 254 of affinity data for UniProtKB/TrEMBL: P04545
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294857(US10112911, Example 1.1)
Affinity DataEC50:  890nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294858(US10112911, Example 1.2)
Affinity DataEC50:  1.13E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294859(US10112911, Example 1.3)
Affinity DataEC50:  250nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294878(US10112911, Example 1.4)
Affinity DataEC50:  1.14E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294913(US10112911, Example 1.5)
Affinity DataEC50:  810nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294914(US10112911, Example 1.6)
Affinity DataEC50:  1.59E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294942(US10112911, Example 1.7)
Affinity DataEC50:  830nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294943(US10112911, Example 1.8)
Affinity DataEC50:  450nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294944(US10112911, Example 1.9)
Affinity DataEC50:  4.09E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294945(US10112911, Example 1.10)
Affinity DataEC50:  430nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294946(US10112911, Example 1.11)
Affinity DataEC50:  1.41E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294947(US10112911, Example 1.12)
Affinity DataEC50: >3.20E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294948(US10112911, Example 1.13)
Affinity DataEC50:  200nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294949(US10112911, Example 1.14)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294950(US10112911, Example 1.15)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294951(US10112911, Example 1.16)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294952(US10112911, Example 1.17)
Affinity DataEC50:  540nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294953(US10112911, Example 1.18)
Affinity DataEC50:  1.16E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294954(US10112911, Example 1.19)
Affinity DataEC50:  150nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294955(US10112911, Example 1.20)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294956(US10112911, Example 1.21)
Affinity DataEC50:  2.07E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294957(US10112911, Example 1.22)
Affinity DataEC50:  400nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294958(US10112911, Example 1.23)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294959(US10112911, Example 1.24)
Affinity DataEC50: >6.68E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294960(US10112911, Example 1.25)
Affinity DataEC50: >7.29E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294961(US10112911, Example 1.26)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294962(US10112911, Example 1.27)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294963(US10112911, Example 1.28)
Affinity DataEC50:  3.10E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294964(US10112911, Example 1.29)
Affinity DataEC50: >3.16E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294965(US10112911, Example 1.30)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294966(US10112911, Example 1.31)
Affinity DataEC50:  2.00E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294967(US10112911, Example 1.32)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294968(US10112911, Example 1.33)
Affinity DataEC50:  300nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294969(US10112911, Example 1.34)
Affinity DataEC50: >3.10E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294970(US10112911, Example 1.35)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294971(US10112911, Example 1.36)
Affinity DataEC50: >6.60E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294972(US10112911, Example 1.37)
Affinity DataEC50:  400nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294973(US10112911, Example 1.38)
Affinity DataEC50: >3.10E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294974(US10112911, Example 1.39)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294975(US10112911, Example 1.40)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294976(US10112911, Example 1.41)
Affinity DataEC50:  1.22E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294977(US10112911, Example 1.42)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294978(US10112911, Example 1.43)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294979(US10112911, Example 1.44)
Affinity DataEC50:  120nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294980(US10112911, Example 1.45)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294981(US10112911, Example 1.46)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294982(US10112911, Example 1.47)
Affinity DataEC50: >1.38E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294983(US10112911, Example 1.48)
Affinity DataEC50:  1.34E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294984(US10112911, Example 1.49)
Affinity DataEC50: >3.20E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294985(US10112911, Example 1.50)
Affinity DataEC50: >3.20E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 254 total ) | Next | Last >>
Jump to: